Evotec (EVT) Stock Chart & Stock Price History → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free EVT Stock Alerts €9.64 -4.54 (-32.02%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Evotec Stock Price Performance5 Day Performance-27.30%1 Month Performance-29.25%3 Month Performance-33.22%6 Month Performance-42.08%Year-To-Date Performance-54.70%1 Year Performance-45.78% Receive EVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> EVT Stock Chart for Thursday, April, 25, 2024 EVT Chart by TradingView Evotec Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024€13.70€14.18+3.50%€14.22€13.79654,746 shs$2.51 billion04/23/2024€13.26€13.70+3.32%€13.81€13.33725,516 shs$2.43 billion04/22/2024€13.26€13.26€13.27€12.94673,258 shs$2.35 billion04/19/2024€13.21€13.45+1.82%€13.45€12.98694,213 shs$2.38 billion04/18/2024€13.21€13.21€13.36€13.01617,970 shs$2.34 billion04/17/2024€13.78€13.21-4.14%€13.36€13.01617,970 shs$2.34 billion Get the Latest News and Ratings for EVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024€13.77€13.78+0.07%€14.06€13.57337,584 shs$2.44 billion04/15/2024€13.77€13.77€14.33€13.661.08 million shs$2.44 billion04/12/2024€13.36€13.30-0.45%€13.64€12.771.24 million shs$2.36 billion04/11/2024€14.39€13.36-7.16%€14.55€13.361.35 million shs$2.37 billion04/10/2024€14.43€14.39-0.28%€14.59€14.33599,521 shs$2.55 billion04/09/2024€14.00€14.43+3.07%€14.62€13.87660,496 shs$2.56 billion04/08/2024€14.00€14.00€14.00€13.70761,007 shs$2.48 billion04/05/2024€14.08€14.11+0.21%€14.20€13.86425,768 shs$2.50 billion04/04/2024€14.09€14.08-0.07%€14.13€13.70631,908 shs$2.49 billion04/03/2024€14.47€14.09-2.63%€14.43€14.00933,891 shs$2.50 billion04/02/2024€14.47€14.47€14.77€14.18796,897 shs$2.56 billion04/01/2024€14.47€14.47€14.77€14.18796,897 shs$2.56 billion03/29/2024€14.38€14.47+0.66%€14.77€14.18796,897 shs$2.56 billion03/28/2024€13.77€14.38+4.39%€14.45€13.76714,193 shs$2.55 billion03/27/2024€13.77€13.77€13.95€13.32521,063 shs$2.44 billion03/26/2024€13.63€13.77+1.06%€13.95€13.32521,063 shs$2.44 billion03/25/2024€13.63€13.63€13.69€13.30508,208 shs$2.41 billion03/22/2024€13.71€13.36-2.55%€14.04€13.31653,888 shs$2.37 billion03/21/2024€13.54€13.71+1.26%€13.73€13.44601,661 shs$2.43 billion03/20/2024€13.54€13.54€13.54€13.02692,011 shs$2.40 billion03/19/2024€12.62€13.54+7.25%€13.54€13.02692,011 shs$2.40 billion03/18/2024€12.62€12.62€13.07€12.621.34 million shs$2.24 billion03/15/2024€12.97€12.62-2.70%€13.07€12.621.34 million shs$2.24 billion03/14/2024€13.25€12.97-2.11%€13.47€12.90495,424 shs$2.30 billion03/13/2024€13.10€13.25+1.15%€13.36€13.07572,172 shs$2.35 billion03/12/2024€13.04€13.10+0.50%€13.10€12.71663,480 shs$2.32 billion03/11/2024€13.04€13.04€13.11€12.76642,461 shs$2.31 billion03/08/2024€13.09€13.09+0.04%€13.20€12.92840,483 shs$2.32 billion03/07/2024€12.90€13.09+1.47%€13.15€12.79598,344 shs$2.32 billion03/06/2024€13.41€12.90-3.80%€13.46€12.79776,869 shs$2.28 billion03/05/2024€13.95€13.41-3.87%€14.02€13.41562,877 shs$2.38 billion03/04/2024€13.95€13.95€13.96€13.55444,073 shs$2.47 billion03/01/2024€13.90€13.64-1.87%€14.01€13.64662,202 shs$2.42 billion02/29/2024€14.09€13.90-1.31%€14.26€13.81458,805 shs$2.46 billionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>02/28/2024€13.89€14.09+1.40%€14.28€13.70515,863 shs$2.50 billion02/27/2024€13.89€13.89€14.08€13.66361,173 shs$2.46 billion02/26/2024€13.99€13.89-0.71%€14.08€13.66361,173 shs$2.46 billion02/23/2024€13.56€13.74+1.36%€13.86€13.51474,299 shs$2.43 billion02/22/2024€13.56€13.56€13.69€13.25411,261 shs$2.40 billion02/21/2024€13.70€13.56-1.06%€13.69€13.25411,261 shs$2.40 billion02/20/2024€13.67€13.70+0.26%€13.75€13.50331,533 shs$2.43 billion02/19/2024€13.67€13.67€13.89€13.58704,108 shs$2.42 billion02/16/2024€13.59€13.59€13.65€13.35902,038 shs$2.41 billion02/15/2024€13.61€13.59-0.15%€13.65€13.35902,038 shs$2.41 billion02/14/2024€13.61€13.61€14.20€13.45828,225 shs$2.41 billion02/13/2024€13.88€13.61-1.95%€14.20€13.45828,225 shs$2.41 billion02/12/2024€13.88€13.88€14.27€13.77404,302 shs$2.46 billion02/09/2024€14.52€14.15-2.55%€14.76€14.00622,173 shs$2.51 billion02/08/2024€14.13€14.52+2.72%€14.75€14.131.34 million shs$2.57 billion02/07/2024€13.25€14.13+6.64%€14.13€13.231.68 million shs$2.50 billion02/06/2024€13.25€13.25€13.41€13.02893,087 shs$2.35 billion02/05/2024€13.24€13.25+0.08%€13.41€13.02893,087 shs$2.35 billion02/02/2024€14.31€13.56-5.28%€14.19€13.431.24 million shs$2.40 billion02/01/2024€14.35€14.31-0.28%€14.48€14.15515,750 shs$2.54 billion01/31/2024€14.30€14.35+0.38%€14.59€14.24527,494 shs$2.54 billion01/30/2024€14.30€14.30€14.39€13.93735,263 shs$2.53 billion01/29/2024€14.45€14.30-1.04%€14.39€13.93735,263 shs$2.53 billion01/26/2024€14.44€14.44€14.91€14.251.01 million shs$2.56 billion01/25/2024€15.02€14.44-3.89%€14.91€14.251.01 million shs$2.56 billion01/24/2024€15.28€15.02-1.70%€15.83€14.981.05 million shs$2.66 billion Related Companies: MorphoSys Stock Price Chart CompuGroup Medical SE & Co. KGaA Stock Price Chart Gerresheimer Stock Price Chart Biotest Aktiengesellschaft Stock Price Chart RHÖN-KLINIKUM Aktiengesellschaft Stock Price Chart Sartorius Aktiengesellschaft Stock Price Chart Carl Zeiss Meditec Stock Price Chart Merck KGaA Stock Price Chart Stratec Stock Price Chart Drägerwerk AG & Co. KGaA Stock Price Chart Receive EVT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter. This page (ETR:EVT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.